Beam Therapeutics Inc. (BEAM) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $242.82M | -34.4% |
| 2024 | $370.28M | -22.6% |
| 2023 | $478.38M | -21.3% |
| 2022 | $608.24M | -6.1% |
| 2021 | $647.72M | +214.2% |
| 2020 | $206.12M | +273.7% |
| 2019 | $55.15M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $242.82M | -34.4% |
| 2024 | $370.28M | -22.6% |
| 2023 | $478.38M | -21.3% |
| 2022 | $608.24M | -6.1% |
| 2021 | $647.72M | +214.2% |
| 2020 | $206.12M | +273.7% |
| 2019 | $55.15M | — |